CN113563280A - Synthetic method of 2-cyanophenothiazine - Google Patents

Synthetic method of 2-cyanophenothiazine Download PDF

Info

Publication number
CN113563280A
CN113563280A CN202110869328.7A CN202110869328A CN113563280A CN 113563280 A CN113563280 A CN 113563280A CN 202110869328 A CN202110869328 A CN 202110869328A CN 113563280 A CN113563280 A CN 113563280A
Authority
CN
China
Prior art keywords
cyanophenothiazine
synthesis
nickel
ligand
mercaptobenzonitrile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202110869328.7A
Other languages
Chinese (zh)
Other versions
CN113563280B (en
Inventor
罗治斌
孙华
张恒铭
高苏皖
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhenjiang Cabo Medical Technology Co ltd
Original Assignee
Zhenjiang Cabo Medical Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhenjiang Cabo Medical Technology Co ltd filed Critical Zhenjiang Cabo Medical Technology Co ltd
Priority to CN202110869328.7A priority Critical patent/CN113563280B/en
Publication of CN113563280A publication Critical patent/CN113563280A/en
Application granted granted Critical
Publication of CN113563280B publication Critical patent/CN113563280B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/101,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/141,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18[b, e]-condensed with two six-membered rings
    • C07D279/20[b, e]-condensed with two six-membered rings with hydrogen atoms directly attached to the ring nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)

Abstract

The invention discloses a synthetic method of 2-cyanophenothiazine, which comprises the following steps: step 1, reacting 4-halogen-3-nitrobenzonitrile serving as a raw material in the presence of sulfide to obtain 3-amino-4-mercaptobenzonitrile; and 2, in the presence of nickel salt, ligand and alkali, reacting 3-amino-4-mercaptobenzonitrile with a compound C to generate 2-cyanophenothiazine, and synthesizing the 2-cyanophenothiazine by using cheap and easily available 4-halogen-3-nitrobenzonitrile as a raw material through fewer two steps. The reagent used in the reaction process is cheap and easy to obtain, and the reaction process has the advantages of short steps, simple and convenient operation, high yield, safe operation and no pollution, and is suitable for industrial production.

Description

Synthetic method of 2-cyanophenothiazine
Technical Field
The invention relates to the technical field of organic synthesis and fine chemicals, in particular to a method for synthesizing 2-cyanophenothiazine.
Background
2-cyanophenothiazine (CAS number 38642-74-9) is an important organic synthesis intermediate, and the medicine prepared from it has multiple medicinal functions, especially has important effects in lowering blood pressure, tranquilizing mind, relieving pain and resisting cancer, and the demand of international market for the intermediate is large. The structural formula of the 2-cyanophenothiazine is shown in the specification
Figure BDA0003188504880000011
The compound is prepared by using 2-chlorophenothiazine and cuprous cyanide as raw materials and reacting in organic solvent with high boiling point, such as quinoline or N-methylpyrrolidone, and the like under the catalysis of iodine or sodium iodide and potassium iodide.
Although the above methods are relatively mature, they have high requirements for raw materials and environment. In the high-temperature reaction process, the 2-cyanophenothiazine product is hydrolyzed into the amide body by a trace amount of water in the raw material or the environment, the impurity is difficult to remove from the product by a solvent recrystallization method, and the product yield is greatly influenced by repeated recrystallization although the content of the amide body can be reduced. Therefore, the industrial synthetic route of 2-chlorophenothiazine is yet to be optimized, and particularly a new synthetic route using new raw materials is yet to be developed.
Disclosure of Invention
Aiming at the defects in the prior art, the invention provides a method for synthesizing 2-cyanophenothiazine.
The technical scheme for solving the problems comprises the following steps: a method for synthesizing 2-cyanophenothiazine comprises the following steps:
step 1, reacting 4-halogen-3-nitrobenzonitrile serving as a raw material in the presence of sulfide to obtain 3-amino-4-mercaptobenzonitrile;
and 2, reacting the 3-amino-4-mercaptobenzonitrile with the compound C in the presence of nickel salt, a ligand and alkali to generate the 2-cyanophenothiazine. The reaction synthesis route is as follows:
Figure BDA0003188504880000012
x in the structural formula of 4-halogen-3-nitrobenzonitrile1Compound C formula wherein X2,X3One selected from F, Cl, Br and I.
Further, in step 1, the sulfide is selected from Na2S,NaHS,K2S,KHS,(NH4)2S,NH4HS,Na2SO3The reaction temperature is 20-100 ℃.
Further, the mass ratio of the sulfide to the 4-halogen-3-nitrobenzonitrile is (3-4): 1.
further, in the step 2, the nickel salt is selected from one of nickel chloride, nickel bromide, nickel acetate, nickel sulfate, nickel perchlorate and nickel trifluoromethanesulfonate, and the reaction temperature is 80-100 ℃.
Further, the mass ratio of the nickel salt to the 3-amino-4-mercaptobenzonitrile is 2-5: 100.
further, in step 2, the ligand is selected from compounds of the following structures:
Figure BDA0003188504880000021
in the ligand structure, R1R2, R3, R4, R5, R6 and R7 are selected from any one of a hydrogen atom, a linear chain or branched chain alkyl group and an aryl group.
Further, the mass ratio of the ligand to the 3-amino-4-mercaptobenzonitrile is 1-2: 20.
further, the synthesis of the ligand comprises two steps: firstly, bromo-pyridine aldehyde ketone derivatives, formaldehyde and amine compounds are condensed under an acidic condition to generate bromo-2-azaindolizine; and step two, coupling bromo-2-azaindolizine and an imidazole derivative to obtain a ligand. The reaction synthesis route is as follows:
Figure BDA0003188504880000022
the invention has the following beneficial effects:
the invention provides a synthesis method of 2-cyanophenothiazine, which takes cheap and easily-obtained 4-halogen-3-nitrobenzonitrile as a raw material and realizes the synthesis of 2-cyanophenothiazine by fewer two steps. The reagent used in the reaction process is cheap and easy to obtain, and the reaction process has the advantages of short steps, simple and convenient operation, high yield, safe operation and no pollution, and is suitable for industrial production.
Detailed Description
The technical solution provided by the present invention is explained in detail with reference to specific embodiments below.
A method for synthesizing 2-cyanophenothiazine comprises the following steps:
step 1, reacting 4-halogen-3-nitrobenzonitrile serving as a raw material in the presence of sulfide to obtain 3-amino-4-mercaptobenzonitrile;
and 2, reacting the 3-amino-4-mercaptobenzonitrile with the compound C in the presence of nickel salt, a ligand and alkali to generate the 2-cyanophenothiazine. The reaction synthesis route is as follows:
Figure BDA0003188504880000031
the structural formula of the 4-halogen-3-nitrobenzonitrile is shown as the following, X1One selected from F, Cl, Br and I;
Figure BDA0003188504880000032
the structural formula of the 3-amino-4-mercapto benzonitrile is shown as follows,
Figure BDA0003188504880000033
the structural formula of the compound c is shown as the following, X2,X3One selected from F, Cl, Br and I;
Figure BDA0003188504880000034
in step 1, the sulfide is selected from Na2S,NaHS,K2S,KHS,(NH4)2S,NH4HS,Na2SO3In the preparation method, the mass ratio of the sulfide to the 4-halogen-3-nitrobenzonitrile is (3-4): 1, the reaction temperature is 20-100 ℃;
in the step 2, the nickel salt is selected from one of nickel chloride, nickel bromide, nickel acetate, nickel sulfate, nickel perchlorate and nickel trifluoromethanesulfonate, and the mass ratio of the nickel salt to the 3-amino-4-mercaptobenzonitrile is 2-5: 100, the reaction temperature is 80-100 ℃;
in step 2, the base is selected from DBU, KOButPotassium tert-butoxide, sodium methoxide, NaH, Cs2CO3、K3PO4In the method, the mass ratio of the alkali to the 3-amino-4-mercaptobenzonitrile is 2-4: 1;
in step 2, the ligand is selected from compounds of the following structure:
Figure BDA0003188504880000041
in the ligand structure, R1,R2,R3,R4,R5,R6,R7Any one selected from a hydrogen atom, a linear or branched alkyl group and an aryl group; the mass ratio of the ligand to the 3-amino-4-mercaptobenzonitrile is 1-2: 20.
the synthesis of the ligand comprises two steps: firstly, bromo-pyridine aldehyde ketone derivatives, formaldehyde and amine compounds are condensed under an acidic condition to generate bromo-2-azaindolizine; and step two, coupling bromo-2-azaindolizine and an imidazole derivative to obtain a ligand. The reaction synthesis route is as follows:
Figure BDA0003188504880000042
preparing a ligand: in the first step, aniline (0.4mL,4.3mmol), 35% aqueous formaldehyde (0.49mL,6.5mmol), 2.94M HCl in ethanol (1.5mL,4.3mmol), 6-bromopyridine-2-carbaldehyde (4.3mmol), and ethanol (7.2mL) were added to a reaction vessel, and the reaction was stirred at room temperature for 15 minutes. Then decompressing and distilling off the solvent, dissolving the obtained crude product in hot acetonitrile, filtering while the crude product is hot, and recrystallizing the crude product through acetonitrile/tetrahydrofuran to obtain corresponding bromo-2-azaindolizine M1 which is an orange solid;
and secondly, dissolving bromo-2-azaindolizine M1(2mmol) and imidazole (2.4mmol) in acetonitrile (10mL), adding palladium acetate (0.1mmol) and potassium phosphate (2.4mmol), heating to 80 ℃, reacting for 8 hours, filtering while hot, and recrystallizing the obtained crude product by acetonitrile/tetrahydrofuran to obtain the corresponding ligand L1.
The reaction synthesis route is as follows:
Figure BDA0003188504880000051
example 1
Dissolving 4-chloro-3-nitrobenzonitrile (18.3g, 100mmol) in water (100mL), stirring, adding NaHS (6.2g, 110mmol), heating to 85 deg.C, reacting for 3h, cooling the reaction mixture to room temperature, adding Na while stirring2SO3(27.7g, 220mmol) and then the pH of the reaction was adjusted to 6 by slow addition of 30% hydrochloric acid for about 2 hours, and finally isolated by extraction with 1, 2-dichloroethane (200mL) and the organic mixture was MgSO 24Drying, filtering and concentrating to obtain a crude product, adding the crude product into 100mL of toluene, heating and refluxing for 30 minutes, then cooling to 5 ℃, separating out a solid, filtering the obtained solid under vacuum, washing with cold toluene, and drying to obtain pure 3-amino-4-mercaptobenzonitrile with the yield of 81%.
Nickel bromide (0.4g, 2mmol) and ligand L1(1.5g, 5mmol) were dissolved in DMF (200mL), potassium tert-butoxide (24.6g, 220mmol) was added, and after stirring at room temperature for 60 minutes, 3-amino-4-mercaptobenzonitrile (15g, 100mmol) and o-dichlorobenzene (16.2g, 110mmol) were added, the reaction was warmed to 100 ℃ for 10 hours, then 100mL of water was added to quench the reaction, and extraction separation was performed with dichloromethane (300 mL). The organic mixture was over MgSO4The crude product was added to 100mL of toluene, refluxed at elevated temperature for 30 minutes, and then cooled to 5 ℃ to precipitate a yellow solid. The resulting yellow solid was filtered under vacuum, washed with cold ether and dried to give pure 2-cyanophenothiazine in 88% yield.
Example 2
4-fluoro-3-nitrobenzonitrile (16.6g, 100mmol) was dissolved in water (100mL), stirring was turned on, and K was added2S (12.1g, 110mmol), heating to 80 ℃ for reaction for 3h, and reactingThe reaction mixture was cooled to room temperature and Na was added with stirring2SO3(27.7g, 220mmol) and then the pH of the reaction was adjusted to 6 by slow addition of 30% hydrochloric acid for about 2 hours, and finally isolated by extraction with 1, 2-dichloroethane (200mL) and the organic mixture was MgSO 24Drying, filtering and concentrating to obtain a crude product, adding the crude product into 100mL of toluene, heating and refluxing for 30 minutes, then cooling to 5 ℃, separating out a solid, filtering the obtained solid under vacuum, washing with cold toluene, and drying to obtain pure 3-amino-4-mercaptobenzonitrile with the yield of 78%.
Nickel chloride (0.26g, 2mmol) and ligand L1(1.9g, 5mmol) were dissolved in DMF (200mL), cesium carbonate (72g, 220mmol) was added, and after stirring at room temperature for 60 minutes, 3-amino-4-mercaptobenzonitrile (15g, 100mmol) and o-dibromobenzene (26g, 110mmol) were added, and the reaction was warmed to 80 ℃ for 10 hours, followed by quenching with 100mL of water, and extraction separation was performed with dichloromethane (300 mL). The organic mixture was over MgSO4The crude product was added to 100mL of toluene, refluxed at elevated temperature for 30 minutes, and then cooled to 5 ℃ to precipitate a yellow solid. The resulting yellow solid was filtered under vacuum, washed with cold ether and dried to give pure 2-cyanophenothiazine in 90% yield.
Example 3
4-bromo-3-nitrobenzonitrile (22.7g, 100mmol) was dissolved in water (100mL), stirring was turned on, and Na was added2S (8.6g, 110mmol), heating to 60 ℃ for 2h, cooling the reaction mixture to room temperature, adding Na while stirring2SO3(27.7g, 220mmol) and then the pH of the reaction was adjusted to 6 by slow addition of 30% hydrochloric acid for about 2 hours, and finally isolated by extraction with 1, 2-dichloroethane (200mL) and the organic mixture was MgSO 24Drying, filtering and concentrating to obtain a crude product, adding the crude product into 100mL of toluene, heating and refluxing for 30 minutes, then cooling to 5 ℃, separating out a solid, filtering the obtained solid under vacuum, washing with cold toluene, and drying to obtain pure 3-amino-4-mercaptobenzonitrile with the yield of 83%.
Nickel sulfate (0.3g, 2mmol) and ligandL1(1.9g, 5mmol) was dissolved in DMF (200mL), DBU (33.4g, 220mmol) was added, and after stirring at room temperature for 60 minutes, 3-amino-4-mercaptobenzonitrile (15g, 100mmol) and o-diiodobenzene (36.3g, 110mmol) were added, and the reaction was warmed to 80 ℃ for 6 hours, then 100mL of water was added to quench the reaction, and extraction separation was performed with dichloromethane (300 mL). The organic mixture was over MgSO4The crude product was added to 100mL of toluene, refluxed at elevated temperature for 30 minutes, and then cooled to 5 ℃ to precipitate a yellow solid. The resulting yellow solid was filtered under vacuum, washed with cold ether and dried to give pure 2-cyanophenothiazine in 87% yield.
Example 4
4-iodo-3-nitrobenzonitrile (27.4g, 100mmol) was dissolved in water (100mL), stirring was turned on, and (NH) was added4)2S (7.5g, 110mmol), heating to 40 ℃ for 2h, cooling the reaction mixture to room temperature, adding Na while stirring2SO3(27.7g, 220mmol) and then the pH of the reaction was adjusted to 6 by slow addition of 30% hydrochloric acid for about 2 hours, and finally isolated by extraction with 1, 2-dichloroethane (200mL) and the organic mixture was MgSO 24Drying, filtering and concentrating to obtain a crude product, adding the crude product into 100mL of toluene, heating and refluxing for 30 minutes, then cooling to 5 ℃, separating out a solid, filtering the obtained solid under vacuum, washing with cold toluene, and drying to obtain pure 3-amino-4-mercaptobenzonitrile with the yield of 84%.
Nickel acetate (0.36g, 2mmol) and ligand L1(1.7g, 5mmol) were dissolved in DMF (200mL) and K was added3PO4(46.6g, 220mmol), and after stirring the reaction at room temperature for 60 minutes, 3-amino-4-mercaptobenzonitrile (15g, 100mmol) and 2-bromochlorobenzene (21g, 110mmol) were added, the reaction was warmed to 90 ℃ for 8 hours, then 100mL of water was added to quench the reaction, and the reaction was separated by extraction with dichloromethane (300 mL). The organic mixture was over MgSO4The crude product was added to 100mL of toluene, refluxed at elevated temperature for 30 minutes, and then cooled to 5 ℃ to precipitate a yellow solid. The resulting yellow solid is filtered under vacuum, washed with cold diethyl ether and dried to give pure 2-cyanoPhenothiazine in 86% yield.
The above description is only a preferred embodiment of the present invention, and not intended to limit the present invention in other forms, and any person skilled in the art may apply the above modifications or changes to the equivalent embodiments with equivalent changes, without departing from the technical spirit of the present invention, and any simple modification, equivalent change and change made to the above embodiments according to the technical spirit of the present invention still belong to the protection scope of the technical spirit of the present invention.

Claims (8)

1. A synthetic method of 2-cyanophenothiazine is characterized by comprising the following steps: the method comprises the following steps:
step 1, reacting 4-halogen-3-nitrobenzonitrile serving as a raw material in the presence of sulfide to obtain 3-amino-4-mercaptobenzonitrile;
and 2, reacting the 3-amino-4-mercaptobenzonitrile with the compound C in the presence of nickel salt, a ligand and alkali to generate the 2-cyanophenothiazine. The reaction synthesis route is as follows:
Figure FDA0003188504870000011
x in the structural formula of 4-halogen-3-nitrobenzonitrile1Compound C formula wherein X2,X3One selected from F, Cl, Br and I.
2. A process as claimed in claim 1 for the synthesis of 2-cyanophenothiazines, wherein: in step 1, the sulfide is selected from Na2S,NaHS,K2S,KHS,(NH4)2S,NH4HS,Na2SO3The reaction temperature is 20-100 ℃.
3. A process as claimed in claim 1 or claim 2, wherein the synthesis of 2-cyanophenothiazine comprises: the mass ratio of the sulfide to the 4-halogen-3-nitrobenzonitrile is (3-4): 1.
4. a process as claimed in claim 1 for the synthesis of 2-cyanophenothiazines, wherein: in step 2, the nickel salt is selected from one of nickel chloride, nickel bromide, nickel acetate, nickel sulfate, nickel perchlorate and nickel trifluoromethanesulfonate, and the reaction temperature is 80-100 ℃.
5. A process as claimed in claim 1 or claim 4, wherein the synthesis of 2-cyanophenothiazine is as follows: the mass ratio of the nickel salt to the 3-amino-4-mercaptobenzonitrile is 2-5: 100.
6. a process as claimed in claim 1 for the synthesis of 2-cyanophenothiazines, wherein: in step 2, the ligand is selected from compounds of the following structure:
Figure FDA0003188504870000012
in the ligand structure, R1,R2,R3,R4,R5,R6,R7Selected from any one of a hydrogen atom, a linear or branched alkyl group and an aryl group.
7. A process as claimed in claim 1 or claim 6, wherein the synthesis of 2-cyanophenothiazine is as follows: the mass ratio of the ligand to the 3-amino-4-mercaptobenzonitrile is 1-2: 20.
8. a method of synthesising 2-cyanophenothiazine as claimed in claim 6 wherein: the synthesis of the ligand comprises two steps: firstly, bromo-pyridine aldehyde ketone derivatives, formaldehyde and amine compounds are condensed under an acidic condition to generate bromo-2-azaindolizine; and step two, coupling bromo-2-azaindolizine and an imidazole derivative to obtain a ligand. The reaction synthesis route is as follows:
Figure FDA0003188504870000021
CN202110869328.7A 2021-07-30 2021-07-30 Synthesis method of 2-cyano phenothiazine Active CN113563280B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110869328.7A CN113563280B (en) 2021-07-30 2021-07-30 Synthesis method of 2-cyano phenothiazine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110869328.7A CN113563280B (en) 2021-07-30 2021-07-30 Synthesis method of 2-cyano phenothiazine

Publications (2)

Publication Number Publication Date
CN113563280A true CN113563280A (en) 2021-10-29
CN113563280B CN113563280B (en) 2024-03-08

Family

ID=78169365

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110869328.7A Active CN113563280B (en) 2021-07-30 2021-07-30 Synthesis method of 2-cyano phenothiazine

Country Status (1)

Country Link
CN (1) CN113563280B (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1583732A (en) * 2004-06-10 2005-02-23 山西大学 Preparation of 2-cyanophenthiazine
CN102532057A (en) * 2011-11-17 2012-07-04 成都理工大学 Copper catalytic synthesis phenothiazine compound
CN111039898A (en) * 2019-12-26 2020-04-21 暨明医药科技(苏州)有限公司 Preparation method of metopimazine intermediate

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1583732A (en) * 2004-06-10 2005-02-23 山西大学 Preparation of 2-cyanophenthiazine
CN102532057A (en) * 2011-11-17 2012-07-04 成都理工大学 Copper catalytic synthesis phenothiazine compound
CN111039898A (en) * 2019-12-26 2020-04-21 暨明医药科技(苏州)有限公司 Preparation method of metopimazine intermediate

Also Published As

Publication number Publication date
CN113563280B (en) 2024-03-08

Similar Documents

Publication Publication Date Title
CN102807591B (en) Double benzimidazole ligand based metal complex and preparation method and application thereof
CN112679420B (en) Preparation method of 2,5-dibromopyridine
CN107216328A (en) A kind of synthetic method of α Ka Bolin class compounds
US4332809A (en) Pyridinecarboxamide derivatives and process for the preparation thereof
CN114805314A (en) Synthesis method of Ensaitevir
CN114605328A (en) Preparation method of 6-chloro-2-methyl-2H-indazole-5-amine
CN111499586B (en) Synthesis method of 5,5' -triazene bridged bis (2-methyl-4-nitro-1, 2, 3-triazole) compound
CN112358443B (en) Pyridine compound and preparation method thereof
CN113563280A (en) Synthetic method of 2-cyanophenothiazine
CN106632312A (en) Apixaban related substance, intermediate, preparation method and applications thereof
CN113278021B (en) Preparation method of 1, 7-diazaspiro [3.5] nonane-7-tert-butyl formate and oxalate thereof
CN114634428A (en) Microwave condition preparation method of 6-anilino/p-toluidino-2-naphthalenesulfonic acid
CN110590601B (en) Synthesis method of malononitrile
WO2007089193A1 (en) A process for preparing 2-hydroxy-3- [5- (morpholin-4-ylmethyl)pyridin-2-yl] lh-indole-5-carbonitrile as a free base or salts thereof
CN113004248A (en) Method for synthesizing carbazole compound by catalyzing hydrocarbon amination reaction with cobalt
CN105601646B (en) 4 [6 (methyl mercapto) benzo [1,2 d:5,4 d '] two [base of 1,3] oxazoles 2] benzoic acid preparation method
CN112645872A (en) Preparation method of pyridine nitrogen oxide derivative intermediate
TWI691495B (en) Preparation method for tyrosine kinase inhibitor and intermediates thereof
CN113072539A (en) Chemical synthesis method of pantoprazole dimer
KR102067855B1 (en) Method for preparing xanthene-based compound comprising tertiary amine
CN110845405A (en) Synthesis method of 7-chloroquinaldine
CN114573467B (en) Synthesis process of 2, 4-dimethyl-3-aminobenzoic acid
CN115772115B (en) Synthesis method of aryl pyridine bromo-derivative
JPS597699B2 (en) Method for producing indolines
CN114702451B (en) Preparation method of clonazepam and intermediate thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant